Publications

Us2.ai echocardiographic analysis led to a 70% reduction in measurement and report creation time compared to manual methods, as published in the Journal of Echocardiography.

Published in Nature Hypertension Research, this study used Us2.ai to support healthcare workers in South Africa obtain LVH measurements despite limited training, hand-held sonography devices, difficult imaging conditions, and limited personal resources for analysis.

The CUMIN study, published in European Heart Journal Digital Health, showcases the technical feasibility of AI-POCUS with an EchoNous Kosmos in the hands of novice nurses and opens new possibilities for redefining how we approach cardiac care, particularly in regions with limited resources. The fusion of AI, POCUS and nursing expertise holds the promise of…

The first fully automated AI software with validated global longitudinal strain in patients with and without atrial fibrillation; plus regional strain validated in real-world datasets; plus accurate identification of patients with heart failure, as well as those with regional wall-motion abnormalities, published in the European Heart Journal’s Digital Health.

Remarkable recent advances have revolutionized the field of heart failure. Survival has improved among individuals with heart failure and a reduced ejection fraction, as published in Nature Medicine.

AI to identify cases and classify types of heart failure (HFpEF or HFrEF) from routine EHR surveillance, published in the Journal of Cardiac Failure.

Aortic stenosis published in JASE. First study of its kind demonstrating the capacity of AI Echo to accurately quantify AoS severity with zero human input beyond image acquisition. See the results and the video.

AI echo mortality prediction published in eBioMedicine. Echo can facilitate risk stratification, comparable in performance to established risk scores and correlated with patient’s quality of life measures. Read the publication.

AI-enabled, home-based cardiac care by nurses – abstract presented at the ESC Heart Failure Congress 2023. AI point-of-care ultrasound can improve access, enabling novice nurses to perform cardiac screening in patients’ homes. Download the results.

AI-based MR severity grading presentation at EACVI 2023. Grading MR severity is essential due to high mortality. We’ve built an automated, machine learning based, multiparametric approach. Download the results.

AI echo for cardiac amyloidosis. ATTR-CM is an ultimately fatal cause of heart failure. Manual analysis is slow and highly variable. We showed that automated AI echo can identify predictors of mortality. View the poster.

Strain is a sensitive measure of cardiac function, but clinical application remains limited due to expertise requirements and high variability. We showed AI Echo can automate generation and interpretation of strain. See the results.

A formal white paper on how to democratize echocardiography with augmented intelligence. Download the white paper.

AI echo reports with AI Point-of-Care ultrasound enable novices to perform heart failure screening

AI interpretation of echocardiograms – a formal validation of echo analysis software published in Nature Communications. Download the study.

Echo Strain AI – validation of AI auto strain AI-assisted echocardiography presented at the AHA Scientific Sessions

AI echo reports – automated echo diagnosis support for interpretation of systolic and diastolic function published in The Lancet Digital Health

AI echo disease detection at scale – University of Dundee poster on the detection and diagnosis of patients with heart failure from electronic health records

JASE publication on AI Point-of-care Ultrasound with Continuous-Wave Doppler Capability to evaluate aortic stenosis

Machine learning for diastology and heart failure with preserved ejection fraction – editorial published in JASE

Deep learning in echocardiography – an automated AI echo workflow validation presented at EuroEcho

Cardiovascular disease is the leading cause of death in women. Reducing the global burden by 2030